COVID-19 Vaccine Manufacturers Will Launch A New Vaccine Early Next Year

Recently, a new variant of COVID-19 virus, Omicron, broke out in Africa, which may lead to a decline in the protection of existing vaccines. In response to this, the COVID-19 vaccine manufacturer took swift action, saying that it would adjust the vaccine to cope with the new variant, and a COVID-19 vaccine against the Omicron virus could be launched in the short term. CNBC, "Barron's" and other foreign media reported that Pfizer and its partner BioNTech stated on November 26 that they are studying the antibody effect of the vaccine against Omicron mutant virus strains. If necessary, the mRNA vaccine can be adjusted within 6 weeks, and Start mass production and shipment within 100 days. Pfizer and BioNTech expect to obtain more laboratory test data within two weeks to determine whether the vaccine needs to be adjusted against the Omicron virus. Other pharmaceutical companies including Johnson & Johnson, AstraZeneca and Moderna also stated that they have closely monitored the emerging mutant virus and are testing their existing vaccines against the latest mutant strain Omicron. Effectiveness.